Basic Information
Basic information for SNHG31-205-64aa
Peptide Name SNHG31-205-64aa
Genome Position chr2:214963320-214963511[+]
Species Human
Peptide Sequence MDKFLDTYTLPRLSQEEIESLNRPITSSEIEAVIKNLPTKKSPGPDGFTAEFYQSIKKSWYNVC
Peptide Length 64
Unique No (SNHG31-204-64aa)
Grand Average of Hydropathicity -0.5906
Relative Molecular Mass 8491.41
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000229267;SNHG31
Transcript ID/Name ENST00000670391;SNHG31-205
Transcript Length 2203
Coding Ability 0.3168
DNA Sequence Corresponding to Peptide ATGGATAAATTTCTGGACACATATACCCTCCCAAGACTGAGCCAGGAAGAAATTGAATCCCTGAATAGACCAATAACAAGTTCTGAAATTGAGGCAGTAATAAAAAACTTACCAACCAAAAAGAGCCCAGGACCAGATGGATTCACAGCTGAATTCTACCAGAGTATAAAGAAGAGCTGGTACAATGTCTGC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :